News
Cell migration and angiogenesis are key steps in tumor metastasis. However, the mechanism of migration regulated by vascular endothelial growth factor (VEGF), a potent regulator of angiogenesis ...
To investigate the effect of ginsenoside Rg1 on the migration, adhesion, proliferation, and VEGF expression of endothelial progenitor cells (EPCs). EPCs were isolated from human peripheral blood ...
VEGFR2 binds smaller sub-types of VEGF-A, mature VEGF-C, mature VEGF-D and VEGF-E. Signaling from this receptor is the primary way in which endothelial cell migration, proliferation and survival ...
New role for vascular endothelial growth factor (VEGF) in regulating skin cancer stem cells. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2011 / 10 / 111020024331.htm ...
Vascular endothelial growth factor (VEGF) is pivotal for blood vessel formation and haematopoiesis, but its effect on stem cells has remained unclear. In 27 June Nature, Hans-Peter Gerber and ...
The global vascular endothelial growth factor inhibitors market is poised to reach USD 10.2 billion by 2023, according to a new report by Technavio.
Vascular endothelial growth factor (VEGF) is a signalling protein that promotes the growth of new blood vessels. VEGF forms part of the mechanism that restores the blood supply to cells and ...
Mark R. Nicolls 1, Shiro Mizuno 2, Laima Taraseviciene-Stewart 3, Laszlo Farkas 4, Jennifer I. Drake 4, Aysar Al Husseini 4, Jose G. Gomez-Arroyo 4, Norbert F. Voelkel 4, Herman J. Bogaard 5, New ...
Background: Bevacizumab, a monoclonal antibody against vascular endothelial growth factor A (VEGF), has shown significant clinical benefit in a number of advanced or metastatic cancer settings. We ...
Vascular endothelial growth factor (VEGF)-targeted therapy for the treatment of adult metastatic Xp11 translocation renal cell carcinoma.. JCO 28 , 4606-4606 (2010). DOI: ...
SEATTLE — In this Healio Video Perspective from the ARVO meeting, Jennifer I. Lim, MD, discusses anti-VEGF therapy for the treatment of proliferative sickle cell retinopathy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results